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The prognosis of diabetic patients with high
ankle-brachial index depends on the coexistence of
occlusive peripheral artery disease
Victor Aboyans, MD, PhD,a,b Philippe Lacroix, MD,a,b Minh-Hoang Tran, MD,a Claire Salamagne, MD,a
Sophie Galinat, MD,c Françoise Archambeaud, MD,c Michael H. Criqui, MD, MPH,d and
Marc Laskar, MD,a Limoges, France; and La Jolla, Calif
Objectives: High ankle-brachial index (ABI) (>1.40) is associated with poor cardiovascular disease (CVD) prognosis.
Concomittant peripheral artery disease (PAD) is frequent, although undetectable with the ABI in this situation. We
assessed the prognostic value of a high ABI according to the coexistence of occlusive PAD in diabetics.
Methods: In this retrospective longitudinal study, we reviewed the data of 403 consecutive diabetic patients (hospitalized
in tertiary care teaching hospital) who had a Doppler assessment of their lower limbs between 1999 and 2000. They were
classified as “normal” when Doppler waveform patterns (DWP) were normal and ABI within the 0.91 to 1.39 range,
“occlusive-PAD (O-PAD)” when ABI <0.90, or in case of abnormal DWP with normal ABI, “isolated medial calcinosis
(IMC)” if ABI>1.40 with normal DWP, and “mixed disease (MD)” when ABI>1.40 with abnormal DWP. The primary
outcome was the occurrence of any of the following events: death, stroke or transient ischemic attack (TIA), and acute
coronary syndrome.
Results: The patients (65.6  13.2 years, 54.6% females) were classified as normal (14.4%), O-PAD (48.4%), IMC
(16.4%), and MD (20.8%). During a mean follow-up of 6.5 years, the event-free survival curves of O-PAD and MD
groups showed equally poorer prognosis than the IMC and normal groups. Adjusted for age, sex, diabetes type and
duration, traditional CVD risk factors, chronic kidney disease, CVD history and treatments, the presence of occlusive
disease (hazard ratio [HR]: 2.21, 1.16-4.22, P  .016), but not medial calcinosis, was significantly associated with the
primary outcome.
Conclusions: In diabetics with ABI>1.40, only those with concommittant occlusive PAD have poorer prognosis. ( J Vasc
Surg 2011;53:984-91.)
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aAnkle-brachial index (ABI) is an available, straightfor-
ward, reliable, and inexpensive method to detect peripheral
artery disease (PAD),1,2 and it has also been proposed as a
marker of subclinical atherosclerosis and cardiovascular
prognosis.1-3 Diabetes is a powerful risk factor for PAD,
and the measurement of ABI is used to detect PAD in
diabetic patients.4,5 However, in diabetic patients, it is not
infrequent to find very stiff and even incompressible ankle
arteries, leading to a high ABI (1.40).6 This situation is
due to the presence of medial calcinosis (MC), a specific
disease distinct from atherosclerosis, corresponding to the
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984alcification of themedial layer, without protrusion into the
rterial lumen.7
Recently, several studies showed that a high ABI is also
ssociated with a poorer outcome, both in the general
opulation3,8,9 and in patients with coronary artery dis-
ase.10 However, two clinical studies have shown that a
igh ABI is often associated with occlusive PAD, which
annot be detected then by ABI due to the arterial wall
tiffness.6,11 Of note, Wang et al showed an increased
roportion of claudicants in patients with ABI1.40 com-
ared with those with an ABI within the 1.00 to 1.30
ange, suggestive of an increased risk of occlusive disease
ith an increasing ABI.12 In the US Nationwide PART-
ERS study, high ABI (1.40) was associated with a
hreefold risk excess for foot ulcer.13 Also in Native
mericans with diabetes, radiographic MC was associ-
ted with a 5.5 times increased risk for an ipsilateral
mputation, suggestive of concomitant occlusive dis-
ase.14 As a consequence, it remains unclear whether the
oorer prognosis in case of a high ABI is related to an
ssociated occlusive PAD, or whether MC per se is
ssociated with a worse outcome.
In this retrospective longitudinal study focused on
iabetic patients, we attempted to compare their prognosis
ccording to the type of disease (medial calcinosis and/or
therosclerotic occlusive PAD). We hypothesized that in
iabetic patients with a high ABI, the risk factors and the
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Volume 53, Number 4 Aboyans et al 985coexistence of other localization of atherosclerosis would
vary according to a coexistent occlusive PAD. Beyond, we
hypothesized that the CVD prognosis would differ accord-
ing to the coexistence of an occlusive PAD.
METHODS
We systematically reviewed the medical charts of 403
consecutive patients hospitalized in the department of in-
ternal medicine of our university hospital between January
1, 1999 and December 31, 2000 for the management of
diabetes and during which they had a continuous-wave
Doppler assessment of the lower limbs arteries in our
vascular laboratory. These patients were either hospitalized
for a recent onset of diabetes, or for an annual check-up, or
mostly for poor glycemic control requiring therapy recon-
sideration. The Doppler assessment and ABI measurement
was required either for symptoms or absent pulses or as a
systematic screening protocol to assess the arterial compli-
cations of diabetes.
Baseline data. The baseline clinical data were col-
lected and defined as follows: the diabetes length corre-
sponded to the interval between the first diagnosis of
diabetes and the index hospitalization. Smoking was de-
fined by current or past regular smoking. Hypercholester-
olemia was defined by a blood level of total-cholesterol
240 mg/dL and/or LDL-C 160 mg/dL and/or by
taking lipid-lowering drugs for this purpose. Patients were
considered hypertensive if they were treated for hyperten-
sion, or if the systolic blood pressure at admission was
140 mmHg or the diastolic blood pressure was90 mm
Hg on average of the two first measurements after admis-
sion. Chronic kidney disease (CKD) was defined in case of
chronic renal dialysis or when the estimated glomerular
filtration rate (eGFR) according to theMDRD formula was
below 60mL/min/1.73m
2
.15 Clinical PADwas defined as
any history of lower limbs arterial revascularization, or
typical intermittent claudication reported in the medical
chart. Clinical cerebrovascular disease (CBVD) was defined
as any history of stroke, transient ischemic accident, or
carotid revascularization. Similarly, clinical coronary artery
disease was defined as any history of acute myocardial
infarction, angina, or coronary revascularization.
Vascular assessment. The ABI was measured with the
continuous Doppler probe and an adequate sized blood
pressure cuff. The systolic pressure of the posterior tibial
Table I. Patient classification according to the legs’ catego
Left Normal Isolated MC (
Normal Normal IMC
Isolated MC (IMC) IMC IMC
Occlusive PAD (O-PAD) O-PAD MD
Mixed disease (MD) MD MD
MC, Medial calcinosis; MD, mixed disease; PAD, peripheral artery disease.(PT), anterior tibial (AT), and brachial arteries was mea- wured. The ABI was calculated by dividing the highest
ystolic pressure between the PT and AT by the highest
rachial systolic pressures. The inter- and intraobserver
ariability of ABI measurement are reported elsewhere.16
he ABI results for each leg were categorized among one of
he following groups: low ABI (0.90), normal ABI (0.91-
.39), and high ABI (1.40).
All the recorded Doppler waveforms were indepen-
ently analyzed by two experienced vascular physicians
V.A., P.L.) who were unaware of the other baseline and
ollow-up data. At that period, a continuous wave Doppler
robe (Diadop 300; Diatecnic, Toulouse, France) was used
o assess the blood flow at the levels of common and
uperficial femoral arteries, as well as the popliteal, posterior
ibial, and pedal arteries. The Doppler waveform patterns
DWP) were considered as normal if they were triphasic at
he level of common femoral, superficial femoral, and pop-
iteal arteries and bi- or triphasic at the level of the posterior
ibial and dorsalis pedis arteries. Any DWP that differed
rom this description was considered as abnormal, except
or an isolated absent dorsalis pedis artery Doppler signal,
hich could be related to an arterial hypoplasia. For each
eg, in case of discordant results between the DWP reading
onclusions of the two physicians, the waveforms were
e-analyzed jointly and discussed between the two readers,
nd a final decision was made. Following the DWP analysis
nd the ABI measurement, each leg was classified in one of
he following four mutually exclusive categories: “occlusive
AD (O-PAD)” in case of low-ABI or in case of abnormal
WP with normal ABI; “IMC” in case of high ABI with
ormal DWP, “MD” in case of high ABI with abnormal
WP, and “normal” if both ABI values and DWP analyses
ere normal. After this classification per leg, each patient
as classified in one of the same four categories according
o the classification of both legs as displayed in Table I.
Concomitant to the assessment of the lower limbs, a
arotid Duplex assessment was also performed to detect
erebrovascular disease, as a part of a systematic screening
n our laboratory.17 Carotid arteries were assessed using the
CTUAL HDI 3000 (Philips Ultrasound, Bothell, Wash)
ltrasound machine with a linear 7.5 MHz probe. Com-
on or internal carotid artery plaque was defined as a focal
idening of the arterial wall, relative to adjacent segments,
ith a luminal protrusion of more than 1.5 mm, with or
Right
) Occlusive PAD (O-PAD) Mixed disease (MD)
O-PAD MD
MD MD
O-PAD MD
MD MDries
IMCithout calcifications.18 The performances of our labora-
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April 2011986 Aboyans et altory regarding the carotid disease imaging are published
elsewhere.18
Follow-up and outcome. The follow-up period ended
on April 1, 2008. The medical charts of the patient in any of
the departments of our hospital were reviewed, and in the
absence of recent (12 months) data, the family physicians
were contacted. The following data were systematically re-
trieved: death, the occurrence of fatal or nonfatal acute coro-
nary syndrome (ACS), stroke or transient ischemic attack
(TIA), coronary or carotid revascularization, lower limb am-
putation, and hospitalization related to PAD (amputation,
arterial ulcer management, and critical limb ischemia).
The primary outcome was composite, combining the
total mortality with nonfatal ACS, stroke, or TIA, which-
ever occurred first. Two secondary outcomes were defined:
the first combined death, non-fatal MI, nonfatal stroke/
TIA, and coronary or carotid revascularization. Another
secondary outcome combined PAD-related complications:
amputation or hospitalization for PAD (with or without
revascularization), whichever occurred first.
Statistical methods. Data are reported as mean SD.
In the univariate analysis, risk factors for the occurrence of
the primary outcome were analyzed using the 2 test for
discrete variables and Student t-test for continuous vari-
ables. Multiple logistic regression analysis was used to
determine the risk factors associated with different PAD
Table II. Risk factors, CVD, and therapies in the study po
Variable
Total
(n  403)
Normal
(n  58)
Age (year) 65.6 (13.2) 61.3 (13.5)
Male gender 183 (45.4%) 24 (41.4%)
Type 2 diabetes 297 (90.6%) 51 (87.9%)
Diabetes duration (year) 11.4 (10.2) 10.1 (9.4)
Smoking 106 (26.3%) 10 (17.2%)
Hypercholesterolemia 242 (60.1%) 34 (58.6%)
Hypertension 254 (63.0%) 27 (46.6%)
History of CAD 83 (20.8%) 8 (13.8%)
History of CBVD 40 (9.9%) 4 (6.7%)
Clinical CAD/CBVD 103 (25.5%) 11 (19.0%)
Clinical PAD 57 (14.3%) 0 (0%)
CKD 65 (16.5%) 9 (16.1%)
Carotid plaque 161 (41.0%) 14 (24.2%)
Drug therapies
ACE-Inh/AAII 125 (31.2%) 15 (25.9%)
Beta-blockers 47 (11.7%) 8 (13.8%)
Antiplatelets/VKA 172 (32.7%) 21 (36.2%)
Statins 89 (22.2%) 14 (24.6%)
Insulin 207 (51.5%) 31 (53.5%)
Metformin 161 (40.2%) 19 (32.8%)
Sulfonylureas 240 (59.7%) 30 (51.7%)
Alpha-glucosidase inhibitors 145 (36.1%) 18 (31.0%)
AAII, Angiotensin-II antagonists; ACE-Inh, angiotensin conversion enzym
chronic kidney disease; CVD, cardiovascular disease; PAD, peripheral artery
aP  .05 vs MD group.
bP  .05 vs O-PAD group.
cP  .05 vs normal group.
dP  .05 vs IMC group.categories. For this purpose, all factors were initially intro- tuced in the multivariate model (initial model). Using a
tepwise descending procedure, all the factors with a P 
15 were excluded from the analysis leading to the final
odels which were systematically adjusted for age and sex.
ox regression models were used, putting the presence of
edial calcinosis and occlusive disease as separate and non-
utually exclusive terms, and the models were systemati-
ally adjusted for age, sex, type of diabetes, and major CVD
edications (statins, aspirin, ACE-inhibitors/angiotensin
ntagonists, and beta-blockers). The event-free curves of
AD categories were obtained using the Kaplan-Meier
ethod, and compared by the log-rank test. For all these
ests, a P value .05 was considered as significant. The
-coefficient was calculated to study the inter-rater agree-
ent between the two readers who classified the DWP as
ormal or abnormal per limb. The statistical analyses were
erformed using the Statview 5.0 software (SAS Institute,
ary, NC).
ESULTS
The study population is composed of 183men and 220
omen, of whom more than 90% had type 2 diabetes. The
haracteristics of the study population are presented in
able II.
For the disease classification per limb, 10 limbs with a
istory of revascularization were systematically classified in
tion and comparisons among the four patient groups
lated medical
calcinosis
(n  66)
Mixed disease
(n  84)
Occlusive PAD
(n  195) P
7 (12.7)a,b 68.1 (12.9)c,d 66.8 (13.0)c,d .05
8 (57.6%)b 41 (48.8%) 80 (41.0%)d ns
2 (93.9%) 72 (85.7%) 180 (92.2%) ns
5 (7.8)a 15.2 (12.1)b,c,d 10.4 (9.7)a .05
7 (25.8%) 25 (29.8%) 54 (27.7%) ns
2 (63.6%) 53 (63.1%) 113 (58.0%) ns
3 (65.2%)N 61 (72.6%)c 123 (63.1%)c .02
6 (9.2%)a,b 27 (32.5%)c,d 42 (21.7%)d .01
3 (4.6%)a 17 (20.5%)b,d 16 (8.3%)a .01
9 (13.8%)a 35 (42.7%)b,c,d 48 (25.0%)a .001
0 (0%)a,b 21 (25%)c,d 36 (18.7%)c,d ns
5 (7.7%)a 17 (20.7%)C 34 (17.9%) ns
8 (28.6%)a,b 37 (46.8%)c,d 92 (47.7%)c,d .001
0 (30.3%) 31 (36.9%) 59 (30.4%) ns
7 (10.6%) 8 (9.5%) 24 (12.4%) ns
2 (33.3%)a 47 (56.0%)b,c,d 82 (42.3%)a .03
5 (22.7%) 20 (23.8%) 40 (20.6%) ns
8 (42.4%) 47 (56.0%) 101 (52.1%) ns
3 (50.8%)c 30 (35.7%) 79 (40.7%) ns
9 (74.2%)a,b,c 45 (53.6%)d 116 (59.8%)a .04
5 (37.9%) 32 (38.1%) 70 (36.1%) ns
itors; CAD, coronary artery disease; CBVD, cerebrovascular disease; CKD,
se; VKA, vitamin-K antagonists.pula
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Volume 53, Number 4 Aboyans et al 987of DWP was concordant between the two readers in 757
limbs, with an excellent –coefficient at 0.90. For the 39
limbs with discordant conclusions, the DWP were re-
analyzed by both readers together and were classified accord-
ingly as “normal” in 20 cases and “abnormal” in 19 cases.
According to the ABI and DWP analyses of the 796 re-
maining limbs, the patients were classified within the four
prespecified groups as follows: O-PAD: 195 (48.4%), IMC:
66 (16.4%),MD: 84 (20.8%), and normal: 58 (14.4%). The
characteristics of the four groups and their comparisons are
displayed in Table II. Overall patients in the “normal”
group were younger with the shortest duration of diabetes,
while those in the MD group were older with the longest
diabetes duration. Also, the proportion of patients with a
clinical history of CVD was higher in the latter group.
When comparing the two subgroups with high ABI, CKD
was significantly more frequent in the MD group. Of note,
the proportion of patients under sulfonylureas was signifi-
cantly higher in patients with IMC compared with the three
other groups.
A multivariate analysis was performed in three distinct
models to detect risk factors associated with any of the three
vascular diseased groups, taking the normal group as refer-
ence. The results are presented in Table III. Except for age,
the other associated risk factors differed between the sub-
groups. Smoking and hypertension were associated with
Table III. Risk factors associated with different vascular c
Isolated MC
Age (year) 1.04 (1.00-1.08)
P  .051
Male gender 2.93 (1.27-6.76)
P  .011
Hypertension —
Diabetes duration (year) —
Smoking —
CKD 0.29 (0.08-1.11)
P  .071
Sulfonylureas 2.72 (1.22-6.10)
P  .015
CKD, Chronic kidney disease.
Table IV. Association between lower limbs arterial disease
Unadjusted
Normal 1
Isolated medial calcinosis 1.26 (0.56-2.83)
Occlusive disease 2.86 (1.47-5.56)c
Mixed disease 2.77 (1.31-5.84)c
CKD, Chronic kidney disease.
aAdjusted for age, sex, type of diabetes, diabetes duration.
bModel 1  smoking, hypertension, hypercholesterolemia, CKD.
cP  .01.
dP  .05.the presence of occlusive disease (either O-PAD or MD). wn the other hand, male gender and the use of sulfonyl-
reas were associated with IMC, but not in case of MD.
inally, in the absence of concomitant occlusive disease,
enal disease was inversely associated with medial calcinosis.
Regarding the coexistence of atherosclerosis in other
ites than the lower limb, we assessed the association be-
ween carotid plaque and the different patterns of lower
imbs PAD, adjusted for several potential confounders,
uch as age, sex, diabetes type, and duration and CVD risk
actors (Table IV). In the unadjusted model, both patterns
ith occlusive disease (with or without MC) were signifi-
antly associated with the presence of carotid plaque. This
ssociation remained significant for O-PAD after serial
djustments, while only a nonsignificant trend has been
ound in case of MD. Notably, IMC was not associated
ith increased prevalent carotid plaque.
During a mean follow-up of 6.5  2.3 years, 137
atients died (34%). The CVD events occurred during this
eriod are detailed in Table V. Compared with the normal
roup, the CVD events-free survival rates were lower in the
-PAD and MD groups over time, while the prognosis in
he IMC group was intermediate (Figs 1 and 2). Similarly,
AD events-free curves were poorer in the two groups with
cclusive disease (Fig 3).
We performed two sets of multivariate analyses to study
he association of medial calcinosis and occlusive disease
ions: final models
Mixed disease Occlusive PAD
1.04 (1.01-1.07)
P  .021
1.03 (1.01-1.06)
P  .015
1.13 (0.47-2.70)
P  .781
1.13 (0.47-2.70)
P .731
2.41 (1.06-5.46)
P  .035
1.72 (0.91-3.24)
P  .092
1.04 (1.00-1.08)
P  .063
—
2.53 (0.88-7.31)
P .085
2.49 (1.09-5.71)
P .03
— —
— —
carotid plaque
Model 1a Model 2b
1 1
1.32 (0.51-3.40) 1.06 (0.40-2.80)
2.91 (1.33-6.40)c 2.43 (1.09-5.40)d
2.45 (1.02-5.87)d 1.99 (0.82-4.85)onditandith the primary composite outcome (Table VI) and the
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April 2011988 Aboyans et alsecondary composite outcome combining death, nonfatal
ACS, nonfatal stroke or TIA, and coronary or carotid
revascularization (Table VII).We found a strong significant
association between the presence of occlusive disease and
the primary and secondary outcomes. We found no inde-
pendent association between medial calcinosis and the out-
comes. Among other factors, a history of clinical CVD or
the presence of CKD was independently associated with
outcomes, with hazard ratios of similar magnitudes.
DISCUSSION
Our findings suggest that the poorer prognosis of
the diabetic patients with an elevated ABI depends on the
coexistence of occlusive PAD, and in the absence of the
latter, isolated medial calcinosis was not a marker of poorer
outcome in this cohort. We also found different association
between risk factors and different PAD patterns.
In the ABI collaboration study, a meta-analysis compil-
Table V. Events during the follow-up period
Events N (%)
Single outcomes
Death 137 (34.0)
Acute coronary syndromes (ACS) 74 (18.4)
Coronary artery revascularization 20 (5.0)
Stroke/TIA 65 (16.3)
Carotid artery revascularization 14 (3.5)
Peripheral revascularization 3 (0.7)
Amputation 5 (1.2)
Hospitalization for peripheral artery diseasea 19 (4.7)
Composite outcomes
Death or nonfatal cardiovascular events 192 (47.6)
Death or nonfatal peripheral events 149 (37.0)
Death or any event 195 (48.4)
TIA, Transient ischemic attack.
aWithout amputation or revascularization.
Fig 1. Primary outcome (death or nonfatal acute coronary syn-
drome [ACS], stroke or transient ischemic attack [TIA]) according
to the four arterial groups. Composite outcome-free survival
curves in the four subgroups: normal (red curve), isolated medial
calcinosis (blue curve), occlusive peripheral artery disease (PAD)
(orange curve), and mixed disease (green curve). MC, Medial
calcinosis.ing the individual data of almost 50,000 people from 16 (tudies in the general population, the relationship between
he ABI andmortality is shown as being “reverse J-shaped”,
ith the lowest level of risk within the 1.10 to 1.30 range,
nd a significant increased mortality risk for those with
BI 1.40.3 It is well known that diabetes is a major risk
actor for high ABI, due to the development of medial
alcinosis over time in these patients.6,8,13,19 In another
eries of patients referred to a vascular laboratory, a very
trong association (OR at 16) was found between diabetes
nd an ABI 1.40.6 In the current study in hospitalized
iabetic patients, we found a very high prevalence of this
ondition, since 37% had an ABI 1.40, at least on one
imb.
Interestingly, we found a concomitant occlusive disease
ig 2. Secondary outcome (death or nonfatal acute coronary syn-
rome [ACS], stroke or transient ischemic attack [TIA], coronary, or
arotid revascularization) according to the four arterial groups.
urvival curves in the four subgroups: normal (red curve), isolated
edial calcinosis (blue curve), occlusive peripheral artery disease
PAD) (orange curve), and mixed disease (green curve). MC,
edial calcinosis.
ig 3. Peripheral artery disease (PAD) outcome (hospitalization
ith or without revascularization or amputation) according to the
our arterial groups. PAD-related outcomes-free curves in the four
ubgroups: normal (red curve), isolated medial calcinosis (blue
urve), occlusive PAD (orange curve), and mixed disease (green
urve). MC, Medial calcinosis.either in the same limb or the controlateral one) in 56% of
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Volume 53, Number 4 Aboyans et al 989those with a high ABI, and this is comparable to two other
studies: in a series of 510 ambulatory patients undergoing a
noninvasive assessment of lower limbs arteries in two vas-
cular laboratories in SanDiego, 86% of those with an ABI
1.40 had a concomitant occlusive disease diagnosed by the
toe-brachial index (TBI) and distal flow velocity analysis.6
In a Finnish study, the rate of occlusive disease (defined by
TBI 0.60) in patients with an ABI above 1.30 was
reported at 62.5%.11 Further than different population
characteristics within the three series, the different rates are
also partly explained by different definitions and means
used to detect PAD in the presence of stiff ankle arteries.
Beyond the very good agreement between the two readers
to classify O-PAD according to the DWP, another reason
why we are confident of an accurate detection of occlusive
disease in patients with a high ABI is that the group of
patients with MD (high ABI and abnormal DWP) pre-
sented a similar limb prognosis to those with a low ABI,
while those classified as IMC (high ABI but normal DWP)
presented a similar limb prognosis to those with normal
ABI. In addition, the rates of concomitant carotid plaque
were comparable in the O-PAD and MD groups, while
those in the normal or IMC groups had comparable lower
rates.
While the diabetes duration was similar in patients in
Table VI. Predictors of mortality and nonfatal cardiovascu
Unadjus
HR (95% CI)
Medial calcinosis 0.96 (0.50-1.85)
Occlusive disease 2.18 (1.31-3.65)
Diabetes duration (year) —
Hypertension —
Smoking —
Hypercholesterolemia —
Past CVD history —
CKD —
CKD, Chronic kidney disease; CVD, cardiovascular disease; MI, myocardia
All models were systematically adjusted for age, sex, type of diabetes, and C
Table VII. Predictors of death, nonfatal MI, or stroke, co
multivariate analysis
Unadjust
HR (95% CI)
Medial calcinosis 0.95 (0.49-1.82)
Occlusive disease 2.10 (1.26-3.52)
Diabetes duration (year) —
Hypertension —
Smoking —
Hypercholesterolemia —
Past CVD history —
CKD —
CKD, Chronic kidney disease; CVD, cardiovascular disease; MI, myocardia
All models were systematically adjusted for age, sex, type of diabetes, and Cthe normal, IMC, and O-PAD groups, patients with MD sad a disease duration on average of 5 years longer, sug-
esting that the diabetic patients may initially develop
redominantly either occlusive disease or medial calcinosis,
nd an overlap between these two diseases may appear over
ime. The comparison of the three former groups suggests
hat O-PAD occurs predominantly in diabetic patients with
later onset of diabetes, with concomitant risk factors for
therosclerosis such as smoking or hypertension. This ob-
ervation has also been reported by Lehto et al who foundno
ssociation between medial-type calcification and CVD risk
actors, but significant association was found between intima-
ype calcification (related to atherosclerosis) and CVD risk
actors.20 In turn, the diabetic patients of the current study
ith IMC or normal arteries were comparable in terms of age
nd diabetes duration, and themain risk factor associatedwith
MC was the use of sulfonylureas, reminding an old observa-
ion of an increased risk for medial calcinosis under this drug
roup, as shown by soft-tissue X-ray studies of the lower
imbs.21 A relative hyperinsulinemia favoring medial cells
roliferation and deposition of calcium is suggested as a po-
ential pathway to explain this observation.21-23 The associa-
ion between IMC and male gender is original and requires
urther confirmation.
Overall, the prognosis of diabetic patients in this study
s grim, with a 34% mortality at 6.5 years of follow-up, but
vents (MI and stroke)–multivariate analysis
Adjusted model
P HR (95% CI) P
.903 1.18 (0.53-2.60) .686
.005 2.21 (1.16-4.22) .016
— 1.03 (1.01-1.05) .0004
— 0.74 (0.51-1.06) .107
— 0.80 (0.51-1.28) .352
— 1.44 (0.99-2.11) .057
— 1.74 (1.22-2.49) .002
— 1.75 (1.18-2.60) .006
tion.
edications.
ry or carotid revscularization (secondary end point) –
Adjusted model
P HR (95% CI) P
.873 1.23 (0.56-2.74) .614
.005 2.41 (1.27-4.61) .007
— 1.03 (1.01-1.05) .0002
— 0.75 (0.52-1.07) .111
— 0.80 (0.51-1.26) .331
— 1.42 (0.98-2.06) .061
— 1.71 (1.20-2.43) .003
— 1.77 (1.20-2.62) .004
tion.
edications.lar e
tedrona
edimilar to other studies.20,24,25 To our knowledge, this is
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April 2011990 Aboyans et althe first study to link the association between MC and
mortality to the coexistence of atherosclerotic lesions. Us-
ing soft-tissue X-rays, Lehto et al reported increased risk for
mortality and CVD events in case of MC in diabetic pa-
tients.20 Although in their report they outlinedmedial-type
calcification (related to MC) and intimal-type calcification
(related to atherosclerosis), they did not assess whether the
association between MC and mortality was related to the
coexistence of intimal-type lesions, probably because it is
difficult to delineate these two different types of lesions if
they occur concomitantly. Although our methods of inves-
tigation detect only severe lesions with hemodynamic con-
sequences, we have been able to detect a close association
between MC and atherosclerosis in our patients, and point
out the prognostic value of the latter, rather than the
former. Nevertheless, we cannot exclude the presence of
nonocclusive atherosclerotic lesions in those classified in
the IMC group and even in the normal group, and in turn,
it is possible that those classified as O-PAD or normal have
MC to some extent. Yet, our classification reflects more a
predominance of one lesion over another, rather than clear-
cut separate patterns.
Our findings confirm current guidelines recommend-
ing the use of ABI during the follow-up of patients with
diabetes and the use of other noninvasive vascular methods
to detect O-PAD in case of a high ABI.1,2,4,5 However, the
interest of further investigation in asymptomatic patients
with high ABI was not obvious, since they were already
considered as at high risk. Our study provides evidence that
the use of further vascular investigation is necessary in case
of high ABI for an accurate risk stratification of these
patients.
This study has several limitations. First, although we
analyzed systematically all patients referred to our vascular
laboratory during a defined period, the results of this ret-
rospective study require confirmation in a prospective
study. Our findings may only be applied for hospitalized
diabetic patients, mostly severe cases, and we cannot ex-
trapolate our findings to other diabetic cases. Similarly,
further studies in the general population including cases
with high ABI are mandatory. Medial calcinosis also occurs
in the absence of diabetes, and it is unknown whether it is
associated with increased risk in persons without diabetes.
CONCLUSIONS
This study shows the important prognostic information
provided by the ABI in diabetic patients who are usually
systematically considered as at high risk for CVD events.
While several studies found poorer CVD prognosis in case
of high (1.40) ABI, similar to when ABI is 0.90, our
study emphasizes the need for further vascular explorations
in case of an elevated ABI, prior to considering specific
preventive therapies dedicated for those with occlusive
PAD. In turn, patients with high ABI but normal legs
arterial flows are not at higher CVD risk than the average
diabetic patient. Our study requires confirmation in pro-
spective studies, including ambulatory diabetic patients.UTHOR CONTRIBUTIONS
onception and design: VA, PL, FA, MHC, ML
nalysis and interpretation: VA, MHT, CS, PL, SG, MHC
ata collection: MHT, CS
riting the article: VA, PL, MHC, ML
ritical revision of the article: VA, PL, MHT, CS, SG, FA,
MHC, ML
inal approval of the article: VA, PL, MHT, CS, SG, FA,
MHC, ML
tatistical analysis: VA
btained funding: Not applicable
verall responsibility: VA
EFERENCES
1. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin
JL, et al. ACC/AHA 2005 Practice guidelines for the management of
patients with peripheral arterial disease (lower extremity, renal, mesen-
teric, and abdominal aortic): a collaborative report from the American
Association for Vascular Surgery/Society for Vascular Surgery, Society
for Cardiovascular Angiography and Interventions, Society for Vascular
Medicine and Biology, Society of Interventional Radiology, and the
ACC/AHA Task Force on Practice Guidelines (Writing Committee to
Develop Guidelines for the Management of Patients With Peripheral
Arterial Disease): endorsed by the American Association of Cardiovas-
cular and Pulmonary Rehabilitation; National Heart, Lung, and Blood
Institute; Society for Vascular Nursing; TransAtlantic Inter-Society
Consensus and Vascular Disease Foundation. Circulation 2006;113:
e463-654.
2. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes
FGR, on behalf of the TASC II working group. Inter-society consensus
for the management of peripheral arterial disease (TASC II). Eur J Vasc
Endovasc Surg 2007;33:S1-S75.
3. Ankle-Brachial Index Collaboration. Ankle-brachial index combined
with Framingham risk score to predict cardiovascular events and mor-
tality: a meta-analysis. JAMA 2008;300:197-208.
4. American Diabetes Association. Peripheral arterial disease in people
with diabetes. Diab Care 2003;26:3333-41.
5. Redberg RF, Greenland P, Fuster V, Pyörälä K, Blair SN, FolsomAR, et
al. Prevention Conference VI Diabetes and Cardiovascular Disease
Writing Group III: risk assessment in persons with diabetes. Circulation
2002;105:e144-52.
6. Aboyans V, Ho E, Denenberg JO, Ho LA, Natarajan L, Criqui MH.
The association between elevated ankle systolic pressures and peripheral
occlusive arterial disease in diabetic and non-diabetic subjects. J Vasc
Surg 2008;48:1197-203.
7. Mönckeberg JG. U¨ber die Reine Mediaverkalkung der Extremitätenar-
terien und ihr verhalten zur Arteriosklerose, in Virch arch (Pathol Anat)
1903;171:141-67.
8. O’Hare AM, Katz R, Shilipak MG, Cushman M, Newman AB. Mortal-
ity and cardiovascular risk across ankle-arm index spectrum: results from
the Cardiovascular Health Study. Circulation 2006;113:388-93.
9. Resnick HE, Lindsay RS, McDermott MM, Devereux R, Jones KL,
Fabsitz RR, et al. Relationship of high and low ankle brachial index to
all-cause mortality. The Strong Heart Study. Circulation 2004;109:
733-9.
0. Aboyans V, Lacroix P, Postil A, Guilloux J, Rolle F, Cornu E, et al.
Subclinical peripheral arterial disease and incompressible ankle arteries
are both long-term prognostic factors in patients undergoing coronary
artery bypass grafting. J Am Coll Cardiol 2005;46:815-20.
1. Suominen V, Rantanen T, Venermo M, Saarinen J, Salenius J. Preva-
lence and risk factors of PAD among patients with elevated ABI. Eur J
Vasc Endovasc Surg 2008;35:709-14.
2. Wang JC, Criqui MH, Denenberg JO, McDermott MM, Golomb BA,
Fronek A. Exertional leg pain in patients with and without peripheral
arterial disease. Circulation 2005;112:3501-8.
22
2
2
2
JOURNAL OF VASCULAR SURGERY
Volume 53, Number 4 Aboyans et al 99113. Allison MA, Hiatt WR, Hirsch AT, Coll JR, Criqui MH. A high
ankle-brachial index is associated with increased cardiovascular disease
morbidity and lower quality of life. J AmColl Cardiol 2008;51:1292-8.
14. Everhart JE, Pettitt DJ, Knowler WC, Rose FA, Bennett PH. Medial
arterial calcification and its association with mortality and complications
of diabetes. Diabetologia 1988;31:16-23.
15. National Kidney Foundation. K/DOQIClinical Practice Guidelines for
chronic kidney disease: evaluation, classification, and stratification. Am J
Kidney Dis 2002;39(Suppl 1):S1-266.
16. Aboyans V, Lacroix P, Lebourdon A, Preux P-M, Ferrières J, Laskar M.
The intra- and interobserver variability of ankle-arm blood pressure
index according to its mode of calculation. J Clin Epidemiol 2003;56:
215-20.
17. Lacroix P, Aboyans V, Criqui MH, Bertin F, Bouhamed T, Archambe-
aud F, et al. Type-2 diabetes and carotid stenosis: a proposal for a
screening strategy in asymptomatic patients. Vasc Med 2006;11:93-9.
18. Aboyans V, Guilloux J, Lacroix P, Yildiz C, Postil A, Laskar M.
Common carotid intima-media thickness measurement is not a perti-
nent factor for secondary cardiovascular events after coronary bypass
surgery. A prospective study. Eur J Cardiothor Surg 2005;28:415-9.
19. Resnick HE, Foster GL. Prevalence of elevated ankle-brachial index in
the United States 1999 to 2002. Am J Med 2005;118:676-9.tions in non-insulin-dependent diabetes mellitus. Arterioscler Thromb
Vasc Biol 1996;16:978-83.
1. Dobrev D, Manolov D, Zlateva S, Vakov L, Khristov V. Clinical x-ray
studies of arterial calcifications in the lower extremities of diabetics. Vutr
Boles 1981;20:54-61.
2. Fadini GP, Pauletto P, Avogaro A, RattazziM. The good and the bad in
the link between insulin resistance and vascular calcification. Athero-
sclerosis 2007;193:241-4.
3. Olesen P, Nguyen K, Wogensen L, Ledet T, Rasmussen LM. Calcifica-
tion of human vascular smooth muscle cells: associations with osteopro-
tegerin expression and acceleration by high-dose insulin. Am J Physiol
Heart Circ Physiol 2007;292:H1058-64.
4. Dormandy JA, Betteridge DJ, Schernthaner G, Pirags V, Norgren L, on
behalf of the PROactive investigators. Impact of peripheral arterial
disease in patients with diabetes—results from PROactive (PROactive
11). Atherosclerosis 2009;202:272-81.
5. Ogren M, Hedblad B, Engström G, Janzon L. Prevalence and prognostic
significance of asymptomatic peripheral arterial disease in 68-year-old men
with diabetes. Results from the population study ‘MenBorn in 1914’ from
Malmö, Sweden. Eur J Vasc Endovasc Surg 2005;29:182-9.20. Lehto S, Niskanen L, Suhonen M, Ronnemaa T, Laakso M. Medial
artery calcification. A neglected harbinger of cardiovascular complica- Submitted Jun 6, 2010; accepted Oct 4, 2010.
REQUEST FOR SUBMISSION OF SURGICAL ETHICS CHALLENGES ARTICLES
The Editors invite submission of original articles for the Surgical Ethics Challenges section, following the general
format established by Dr. James Jones in 2001. Readers have benefitted greatly from Dr. Jones’ monthly ethics
contributions for more than 6 years. In order to encourage contributions, Dr. Jones will assist in editing them and will
submit his own articles every other month, to provide opportunity for others. Please submit articles under the heading
of “Ethics” using Editorial Manager, and follow the format established in previous issues.
